The assessment of the mechanism of action of bergenin revealed that its treatment to CRC cells reduced Akt/GSK3β signaling activity, suggesting that it could promote FBW7-mediated Mcl-1 degradation and ultimately apoptosis in CRC cells. Here, AKT1 is linked to colorectal carcinoma.